Nadège Corradini
About
Nadège Corradini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology.
According to data from OpenAlex, Nadège Corradini has authored 134 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Nadège Corradini's work include Sarcoma Diagnosis and Treatment (72 papers), Neuroblastoma Research and Treatments (21 papers) and Tumors and Oncological Cases (18 papers). Nadège Corradini is often cited by papers focused on Sarcoma Diagnosis and Treatment (72 papers), Neuroblastoma Research and Treatments (21 papers) and Tumors and Oncological Cases (18 papers). Nadège Corradini collaborates with scholars based in France, Italy and United Kingdom. Nadège Corradini's co-authors include Daniel Orbach, Véronique Minard‐Colin, Olivier Hartmann, Mathilde Lassalle, Giancarlo Izzi, Marie Anne Raquin, Patrizia Bertolini, Michela Casanova, Dominique Heymann and Andrea Ferrari and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Nadège Corradini
122 papers receiving 2.3k citations
Peers
Nadège Corradini
Erin R. Rudzinski United States
William S. Ferguson United States
Jean‐Claude Gentet France
Eva van den Berg Netherlands
Miguel Reyes‐Múgica United States
Gabriele Amann Austria
Max M. van Noesel Netherlands
David Walterhouse United States
Mahdi Fallah Germany
Kathryn E. Dusenbery United States
Citations per year, relative to Nadège Corradini Nadège Corradini (= 1×)
peers
Erin R. Rudzinski
Countries citing papers authored by Nadège Corradini
Since
Specialization
Citations
This map shows the geographic impact of Nadège Corradini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Corradini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Corradini more than expected).
Fields of papers citing papers by Nadège Corradini
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nadège Corradini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Corradini. The network helps show where Nadège Corradini may publish in the future.
Co-authorship network of co-authors of Nadège Corradini
This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Corradini. A scholar is included among the top collaborators of Nadège Corradini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Corradini. Nadège Corradini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Boudou‐Rouquette, Pascaline, Nadège Corradini, Marie‐Pierre Sunyach, et al.. (2025). Chondrosarcomas: Multidisciplinary review and practical recommendations, on behalf of GroupOs. Bulletin du Cancer. 112(6). 638–655.
2.
Brahmi, Mehdi, Maud Toulmonde, Sarah Winter, et al.. (2025). Ostéosarcome et sarcome d’Ewing récurrents ou réfractaires – Directives françaises des groupes FSG/NETSARC et GroupOs. Bulletin du Cancer. 112(6). 601–610.
3.
Corradini, Nadège, Nicolas Macagno, Daniel Orbach, et al.. (2024). Gastrointestinal stromal tumours (GIST) in children: An update of this orphan disease. Bulletin du Cancer. 112(3). 348–357.
4.
Ferrari, Andrea, Daniel Orbach, Luca Bergamaschi, et al.. (2024). Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis. Pediatric Blood & Cancer. 71(7). e31038–e31038.
5.
Chisholm, Julia, Reineke A. Schoot, Alison Cameron, et al.. (2023). Outcomes in lung-only metastatic rhabdomyosarcoma: An analysis of data from the European paediatric Soft tissue sarcoma Study Group MTS 2008 study. SHILAP Revista de lepidopterología. 2. 100018–100018.
6.
Sparber‐Sauer, Monika, Nadège Corradini, Maria Carmen Affinita, et al.. (2023). Clinical characteristics and outcomes for children, adolescents and young adults with “CIC‐fused” or “BCOR‐rearranged” soft tissue sarcomas: A multi‐institutional European retrospective analysis. Cancer Medicine. 12(13). 14346–14359.
7.
Schoot, Reineke A., Daniel Orbach, Véronique Minard‐Colin, et al.. (2023). Inflammatory Myofibroblastic Tumor With ROS1 Gene Fusions in Children and Young Adolescents. JCO Precision Oncology. 7(7). e2300323–e2300323.
8.
Ferrari, Andrea, Daniel Orbach, Michela Casanova, et al.. (2023). Metastatic adult‐type non‐rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group. Cancer. 129(16). 2542–2552.
9.
Milano, Giuseppe Maria, Daniel Orbach, Michela Casanova, et al.. (2022). Malignant ectomesenchymoma in children: The European pediatric Soft tissue sarcoma Study Group experience. Pediatric Blood & Cancer. 70(2). e30116–e30116.
10.
Minard‐Colin, Véronique, Nadège Corradini, Guy Leverger, et al.. (2021). Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tissue sarcoma Study Group recommendations. European Journal of Cancer. 161. 64–78.
11.
Bompas, Emmanuelle, Maud Toulmonde, Perrine Marec‐Bérard, et al.. (2021). Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network. Bulletin du Cancer. 108(2). 163–176.
12.
Brahmi, Mehdi, Philippe A. Cassier, Armelle Dufresne, et al.. (2020). Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT). PLoS ONE. 15(5). e0233046–e0233046.
13.
Bougeard, Gaëlle, Marie Karanian, Cécile Boulanger, et al.. (2020). Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience. Pediatric Blood & Cancer. 67(9). e28486–e28486.
14.
Orbach, Daniel, Monika Sparber‐Sauer, Theodore W. Laetsch, et al.. (2020). Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies. European Journal of Cancer. 137. 183–192.
15.
Marec‐Bérard, Perrine, Cécile Dalban, Nathalie Gaspar, et al.. (2019). A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma. European Journal of Cancer. 125. 58–68.
16.
Orbach, Daniel, Véronique Mosseri, Daniel Pissaloux, et al.. (2018). Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience. Cancer Medicine. 7(4). 1384–1393.
17.
Ferrari, Andrea, Daniel Orbach, Maria Carmen Affinita, et al.. (2018). Evidence of hydroxyurea activity in children with pretreated desmoid‐type fibromatosis: A new option in the armamentarium of systemic therapies. Pediatric Blood & Cancer. 66(1). e27472–e27472.
18.
Chicard, Mathieu, Léo Colmet‐Daage, Nathalie Clément, et al.. (2017). Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma. Clinical Cancer Research. 24(4). 939–949.
19.
Scalabre, Aurélien, Pascale Philippe‐Chomette, Guillaume Passot, et al.. (2017). Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nationwide study over 14 years. Pediatric Blood & Cancer. 65(4).
20.
Odri, Guillaume, Gaëlle Picarda, Séverine Battaglia, et al.. (2010). Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research. 70(19). 7610–7619.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Erin R. Rudzinski Breakdown of academic impact, for papers by William S. Ferguson Breakdown of academic impact, for papers by Jean‐Claude Gentet Breakdown of academic impact, for papers by Eva van den Berg Breakdown of academic impact, for papers by Miguel Reyes‐Múgica Breakdown of academic impact, for papers by Gabriele Amann Breakdown of academic impact, for papers by Max M. van Noesel Breakdown of academic impact, for papers by David Walterhouse Breakdown of academic impact, for papers by Mahdi Fallah Breakdown of academic impact, for papers by Kathryn E. Dusenbery